DO Dow Jones Newswires Zymeworks to Acquire Theravance Biopharma at $17 per Shr
Dow Jones Newswires
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:TBPH, NASDAQ:ZYME
- Language
- English
Zymeworks to Acquire Theravance Biopharma at $17 per Shr
